Follow
Janet B McGill
Janet B McGill
Washington University School of Medicine
Verified email at dom.wustl.edu
Title
Cited by
Cited by
Year
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ...
New England Journal of Medicine 361 (21), 2019-2032, 2009
24552009
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22502006
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16472012
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial
GL Bakris, V Fonseca, RE Katholi, JB McGill, FH Messerli, RA Phillips, ...
Jama 292 (18), 2227-2236, 2004
12072004
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine Practice 23 (2), 207-238, 2017
11582017
Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial
RW Beck, T Riddlesworth, K Ruedy, A Ahmann, R Bergenstal, S Haller, ...
Jama 317 (4), 371-378, 2017
11522017
AACE comprehensive diabetes management algorithm 2013
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine practice: official journal of the American College of …, 2013
10642013
Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study
PA Hollander, SC Elbein, IB Hirsch, D Kelley, J McGill, T Taylor, SR Weiss, ...
Diabetes care 21 (8), 1288-1294, 1998
9651998
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study
WF Keane, BM Brenner, D De Zeeuw, JP Grunfeld, J McGill, WE Mitch, ...
Kidney international 63 (4), 1499-1507, 2003
7552003
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, Y Handelsman, G Grunberger, D Einhorn, MJ Abrahamson, ...
Endocrine Practice 26 (1), 107-139, 2020
6472020
Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial
PJ Lustman, LS Griffith, RE Clouse, KE Freedland, SA Eisen, EH Rubin, ...
Psychosomatic medicine 59 (3), 241-250, 1997
6321997
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine Practice 22 (1), 84-113, 2016
6302016
American Association of Clinical Endocrinologists and American College of Endocrinology–clinical practice guidelines for developing a diabetes mellitus comprehensive care plan …
Y Handelsman, ZT Bloomgarden, G Grunberger, G Umpierrez, ...
Endocrine Practice 21 (4), 413-437, 2015
5952015
Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants
KM Miller, RW Beck, RM Bergenstal, RS Goland, MJ Haller, JB McGill, ...
Diabetes care 36 (7), 2009-2014, 2013
5902013
Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial
RW Beck, TD Riddlesworth, K Ruedy, A Ahmann, S Haller, D Kruger, ...
Annals of internal medicine 167 (6), 365-374, 2017
5402017
Anxiety and poor glycemic control: a meta-analytic review of the literature
RJ Anderson, AB Grigsby, KE Freedland, M De Groot, JB McGill, ...
The International Journal of Psychiatry in Medicine 32 (3), 235-247, 2002
4702002
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
JB McGill, DJ Schneider, CL Arfken, CL Lucore, BE Sobel
Diabetes 43 (1), 104-109, 1994
4191994
The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American …
LM Laffel, JB McGill, DJ Gans
The American journal of medicine 99 (5), 497-504, 1995
3961995
The effect of ruboxistaurin on nephropathy in type 2 diabetes
KR Tuttle, GL Bakris, RD Toto, JB McGill, K Hu, PW Anderson
Diabetes care 28 (11), 2686-2690, 2005
3682005
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm …
AJ Garber, MJ Abrahamson, JI Barzilay, L Blonde, ZT Bloomgarden, ...
Endocrine Practice 25 (1), 69-101, 2019
3612019
The system can't perform the operation now. Try again later.
Articles 1–20